Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Syst ; 4(4): 379-392.e12, 2017 04 26.
Article in English | MEDLINE | ID: mdl-28365150

ABSTRACT

Cell-to-cell variation in gene expression and the propagation of such variation (PoV or "noise propagation") from one gene to another in the gene network, as reflected by gene-gene correlation across single cells, are commonly observed in single-cell transcriptomic studies and can shape the phenotypic diversity of cell populations. While gene network "rewiring" is known to accompany cellular adaptation to different environments, how PoV changes between environments and its underlying regulatory mechanisms are less understood. Here, we systematically explored context-dependent PoV among genes in human macrophages, utilizing different cytokines as natural perturbations of multiple molecular parameters that may influence PoV. Our single-cell, epigenomic, computational, and stochastic simulation analyses reveal that environmental adaptation can tune PoV to potentially shape cellular heterogeneity by changing parameters such as the degree of phosphorylation and transcription factor-chromatin interactions. This quantitative tuning of PoV may be a widespread, yet underexplored, property of cellular adaptation to distinct environments.


Subject(s)
Gene Regulatory Networks , Genetic Variation , Macrophages/physiology , Computer Simulation , Gene Expression , Gene Expression Regulation , Humans , Interleukin-10/genetics , Interleukin-10/metabolism , Interleukin-10/physiology , Stochastic Processes
3.
IEEE Trans Nanobioscience ; 11(3): 273-88, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22987134

ABSTRACT

Clinical symptoms of microbial infection of the gastrointestinal (GI) tract are often exacerbated by inflammation induced pathology. Identifying novel avenues for treating and preventing such pathologies is necessary and complicated by the complexity of interacting immune pathways in the gut, where effector and inflammatory immune cells are regulated by anti-inflammatory or regulatory cells. Here we present new advances in the development of the ENteric Immunity SImulator (ENISI), a simulator of GI immune mechanisms in response to resident commensal bacteria as well as invading pathogens and the effect on the development of intestinal lesions. ENISI is a tool for identifying potential treatment strategies that reduce inflammation-induced damage and, at the same time, ensure pathogen removal by allowing one to test plausibility of in vitro observed behavior as explanations for observations in vivo, propose behaviors not yet tested in vitro that could explain these tissue-level observations, and conduct low-cost, preliminary experiments of proposed interventions/treatments. An example of such application is shown in which we simulate dysentery resulting from Brachyispira hyodysenteriae infection and identify aspects of the host immune pathways that lead to continued inflammation-induced tissue damage even after pathogen elimination.


Subject(s)
Computational Biology/methods , Gastrointestinal Diseases/immunology , Gastrointestinal Diseases/microbiology , Host-Pathogen Interactions/immunology , Models, Biological , Animals , Computer Simulation , Dendritic Cells/immunology , Dysentery/immunology , Dysentery/microbiology , Epithelial Cells/immunology , Gastrointestinal Tract/immunology , Gastrointestinal Tract/microbiology , Immunity, Mucosal/immunology , Swine , T-Lymphocytes/immunology
4.
PLoS Comput Biol ; 5(1): e1000261, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19132079

ABSTRACT

Nucleoside analogs used in antiretroviral treatment have been associated with mitochondrial toxicity. The polymerase-gamma hypothesis states that this toxicity stems from the analogs' inhibition of the mitochondrial DNA polymerase (polymerase-gamma) leading to mitochondrial DNA (mtDNA) depletion. We have constructed a computational model of the interaction of polymerase-gamma with activated nucleoside and nucleotide analog drugs, based on experimentally measured reaction rates and base excision rates, together with the mtDNA genome size, the human mtDNA sequence, and mitochondrial dNTP concentrations. The model predicts an approximately 1000-fold difference in the activated drug concentration required for a 50% probability of mtDNA strand termination between the activated di-deoxy analogs d4T, ddC, and ddI (activated to ddA) and the activated forms of the analogs 3TC, TDF, AZT, FTC, and ABC. These predictions are supported by experimental and clinical data showing significantly greater mtDNA depletion in cell culture and patient samples caused by the di-deoxy analog drugs. For zidovudine (AZT) we calculated a very low mtDNA replication termination probability, in contrast to its reported mitochondrial toxicity in vitro and clinically. Therefore AZT mitochondrial toxicity is likely due to a mechanism that does not involve strand termination of mtDNA replication.


Subject(s)
DNA Replication/drug effects , DNA, Mitochondrial/metabolism , Models, Biological , Nucleic Acid Synthesis Inhibitors , Reverse Transcriptase Inhibitors/pharmacology , Base Sequence/drug effects , DNA, Mitochondrial/analysis , DNA-Directed DNA Polymerase/metabolism , Deoxyribonucleotides/chemistry , Dose-Response Relationship, Drug , Humans , Kinetics , Nucleosides/chemistry , Zidovudine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...